Jan Weber

4.6k total citations
119 papers, 3.0k citations indexed

About

Jan Weber is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Jan Weber has authored 119 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Infectious Diseases, 43 papers in Virology and 35 papers in Molecular Biology. Recurrent topics in Jan Weber's work include HIV Research and Treatment (42 papers), HIV/AIDS drug development and treatment (35 papers) and HIV/AIDS Research and Interventions (19 papers). Jan Weber is often cited by papers focused on HIV Research and Treatment (42 papers), HIV/AIDS drug development and treatment (35 papers) and HIV/AIDS Research and Interventions (19 papers). Jan Weber collaborates with scholars based in Czechia, United States and Germany. Jan Weber's co-authors include Miguel E. Quiñones‐Mateu, Bikram Chakraborty, Jan Hodek, Héctor R. Rangel, V.S. Bagotzky, Pavel Janda, Michael Marotta, Frank Große, Michael M. Lederman and Patti Kiser and has published in prestigious journals such as Nature, The Lancet and Nucleic Acids Research.

In The Last Decade

Jan Weber

113 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Weber Czechia 29 1.0k 1.0k 699 497 494 119 3.0k
Eun‐Young Kim United States 30 1.9k 1.9× 1.1k 1.1× 1.3k 1.9× 879 1.8× 630 1.3× 75 3.7k
Qinxue Hu China 34 1.1k 1.1× 1.3k 1.3× 984 1.4× 1.0k 2.1× 764 1.5× 101 3.5k
Jun Fukushima Japan 34 583 0.6× 324 0.3× 1.2k 1.8× 1.4k 2.9× 491 1.0× 159 3.9k
Fred C. Krebs United States 26 647 0.6× 518 0.5× 428 0.6× 289 0.6× 380 0.8× 76 1.9k
Indira Hewlett United States 33 1.2k 1.2× 1.3k 1.3× 1.2k 1.7× 590 1.2× 988 2.0× 155 3.7k
Patrick F. Kiser United States 33 620 0.6× 1.1k 1.1× 426 0.6× 139 0.3× 503 1.0× 86 3.5k
Anu Puri United States 33 919 0.9× 471 0.5× 2.6k 3.7× 700 1.4× 393 0.8× 92 4.8k
Takayuki Miyazawa Japan 40 1.9k 1.9× 1.1k 1.1× 2.0k 2.9× 788 1.6× 2.2k 4.4× 269 6.8k
Steven Patterson United Kingdom 34 1.5k 1.5× 709 0.7× 700 1.0× 2.3k 4.7× 787 1.6× 122 4.2k
Yun Zhu China 26 189 0.2× 1.8k 1.8× 1.0k 1.5× 313 0.6× 315 0.6× 75 3.5k

Countries citing papers authored by Jan Weber

Since Specialization
Citations

This map shows the geographic impact of Jan Weber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Weber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Weber more than expected).

Fields of papers citing papers by Jan Weber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Weber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Weber. The network helps show where Jan Weber may publish in the future.

Co-authorship network of co-authors of Jan Weber

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Weber. A scholar is included among the top collaborators of Jan Weber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Weber. Jan Weber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bereczki, Ilona, et al.. (2025). Synthesis of 3′-modified xylofuranosyl nucleosides bearing 5′-silyl or -butyryl groups and their antiviral effect against RNA viruses. European Journal of Pharmaceutical Sciences. 209. 107107–107107.
2.
Priksz, Dániel, Ilona Bereczki, Jan Hodek, et al.. (2025). Synthesis, H2S releasing properties, antiviral and antioxidant activities and acute cardiac effects of nucleoside 5′-dithioacetates. Scientific Reports. 15(1). 2876–2876.
3.
Spiwok, Vojtěch, et al.. (2024). Developing Allosteric Inhibitors of SARS‐CoV‐2 RNA‐Dependent RNA Polymerase. ChemMedChem. 19(23). e202400367–e202400367. 1 indexed citations
4.
Lukšan, Ondřej, et al.. (2024). Upregulation of mRNA Expression of ADGRD1/GPR133 and ADGRG7/GPR128 in SARS-CoV-2-Infected Lung Adenocarcinoma Calu-3 Cells. Cells. 13(10). 791–791. 1 indexed citations
5.
Chalupská, Dominika, Milan Dejmek, Michal Šála, et al.. (2024). Discovery of highly potent SARS-CoV-2 nsp14 methyltransferase inhibitors based on adenosine 5′-carboxamides. RSC Medicinal Chemistry. 15(10). 3469–3476. 5 indexed citations
6.
Kalbáčová, Marie Hubálek, et al.. (2024). Stability and biological response of PEGylated gold nanoparticles. Heliyon. 10(9). e30601–e30601. 10 indexed citations
7.
Novotný, Pavel, Jana Humpolíčková, Stancho Stanchev, et al.. (2024). The zymogenic form of SARS-CoV-2 main protease: A discrete target for drug discovery. Journal of Biological Chemistry. 301(1). 108079–108079.
8.
Reyes‐Gutiérrez, Paul E., Jaroslav Kozák, Yevgen P. Yurenko, et al.. (2023). Helquat dyes targeting G-quadruplexes as a new class of anti-HIV-1 inhibitors. Scientific Reports. 13(1). 6096–6096. 1 indexed citations
9.
Chalupská, Dominika, Karel Chalupský, Petra Krafčíková, et al.. (2023). Rational Design of Highly Potent SARS-CoV-2 nsp14 Methyltransferase Inhibitors. ACS Omega. 8(30). 27410–27418. 13 indexed citations
10.
11.
Herrmann, Lars, Ivan A. Yaremenko, Aysun Çapcı, et al.. (2022). Synthesis and in vitro Study of Artemisinin/Synthetic Peroxide‐Based Hybrid Compounds against SARS‐CoV‐2 and Cancer. ChemMedChem. 17(9). e202200005–e202200005. 29 indexed citations
12.
Lovecká, Petra, Lucie Rárová, David Šaman, et al.. (2021). Triterpenoid–PEG Ribbons Targeting Selectivity in Pharmacological Effects. Biomedicines. 9(8). 951–951. 4 indexed citations
13.
Hodek, Jan, Karel Chalupský, Martin Dračínský, et al.. (2021). Discovery of Modified Amidate (ProTide) Prodrugs of Tenofovir with Enhanced Antiviral Properties. Journal of Medicinal Chemistry. 64(22). 16425–16449. 13 indexed citations
14.
Hodek, Jan, Karel Chalupský, Petra Krafčíková, et al.. (2021). Localization of SARS-CoV-2 Capping Enzymes Revealed by an Antibody against the nsp10 Subunit. Viruses. 13(8). 1487–1487. 11 indexed citations
15.
Janovec, V., Jan Hodek, Jiří Froněk, et al.. (2020). Toll-like receptor dual-acting agonists are potent inducers of PBMC-produced cytokines that inhibit hepatitis B virus production in primary human hepatocytes. Scientific Reports. 10(1). 12767–12767. 18 indexed citations
16.
Weber, Jan, Richard M. Gibson, Jan Hodek, et al.. (2017). Impaired human immunodeficiency virus type 1 replicative fitness in atypical viremic non-progressor individuals. AIDS Research and Therapy. 14(1). 15–15. 11 indexed citations
17.
18.
Quiñones‐Mateu, Miguel E., et al.. (2008). Viral Drug Resistance and Fitness. Advances in pharmacology. 56. 257–296. 24 indexed citations
19.
Horner, Paddy, David Cain, Myra O. McClure, et al.. (1997). Association of Antibodies to Chlamydia trachomatis Heat-Shock Protein 60 kD with Chronic Nongonococcal Urethritis. Clinical Infectious Diseases. 24(4). 653–660. 32 indexed citations
20.
Shaw, R J, et al.. (1985). Role of fibreoptic bronchoscopy in management of pneumonia in acquired immune deficiency syndrome.. BMJ. 291(6501). 1012–1013. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eun‐Young Kim Breakdown of academic impact, for papers by Qinxue Hu Breakdown of academic impact, for papers by Jun Fukushima Breakdown of academic impact, for papers by Fred C. Krebs Breakdown of academic impact, for papers by Indira Hewlett Breakdown of academic impact, for papers by Patrick F. Kiser Breakdown of academic impact, for papers by Anu Puri Breakdown of academic impact, for papers by Takayuki Miyazawa Breakdown of academic impact, for papers by Steven Patterson Breakdown of academic impact, for papers by Yun Zhu
Rankless by CCL
2026